Inhalation

INH0426

Issue link: https://www.e-digitaleditions.com/i/1544305

Contents of this Issue

Navigation

Page 15 of 47

When testing dry powder inhalers (DPIs) for the size of particles discharged during each dose, manufacturers largely choose a test protocol that is recognized by the regulatory community [1-4] and that walks a narrow pathway among device design, typical patient breathing characteristics and design principles of the cascade impactor that size-fractionates the discharged particles [5-12]. 14 April 2026 Inhalation Understanding the setting of flow rate for testing dry powder inhalers (DPIs) A fundamental look at everyday practices Daryl L. Roberts, PhD Applied Particle Principles, LLC Introduction When testing dry powder inhalers (DPIs) for the size of particles discharged during each dose, manu- facturers largely choose a test protocol that is recog- nized by the regulatory community [1-4] and that walks a narrow pathway among device design, typi- cal patient breathing characteristics and design prin- ciples of the cascade impactor that size-fractionates the discharged particles [5-12]. To simplify and standardize testing requirements, the United States Pharmacopeia (USP) [1] and related compendia [2, 3] require the flow rate to be estab- lished with the downstream-to-upstream pressure ratio across the flow control valve at a value of 0.5 or less. is condition is called "critical (sonic)" in the USP and simply "critical" in the European Pharma- copeia (Pharm. Eur.) [2] and the Japanese Pharmaco- poeia [3]. e ratio of 0.5 is widely regarded as being derived from thermodynamic theory of the adiabatic expansion of air [13, 14]. According to this theory, at this pressure ratio condition, the mass flow rate remains fixed no matter how small the downstream pressure becomes, as long as the upstream conditions remain unchanged. is practice is widely adopted in the inhaler testing community and is regarded as a method of eliminating a certain degree of variability from test to test and of maintaining proper D 50 val- ues for each impactor stage, as easy to implement and as independent of the individual testing technician. So far so good; but now let us take one step at a time, hypothetically, into the thoughts of a diligent tester of dry powder inhalers. is person might notice that, curiously, there appear to be no publicly available data that demonstrate or test this theory for control valves in routine inhaler testing practice. Nevertheless, the pharmacopeial compendia do speak to the nature of the flow control valve. According to the Japanese Pharmacopoeia and Pharm. Eur., the flow control valve must be one "with a maximum Cv ≥ 1." Again, curiously, this requirement comes with no definition of Cv. But Pharm. Eur. goes further and says, "with maximum Cv ≥ 1, (e.g., type 8FV12LNSS, Parker Hannifin plc., Barnstaple, EX31 1NP, UK), or equiv- alent." Until approximately calendar 2010, the USP mentioned this same Parker valve (type 8FV12LN) and included a footnote with the parameter Cv as follows: "with maximum (Cv) a ≥ 1" (the letter "a" here is the footnote indicator in the USP text). e current USP volume <601> retains this same foot- note but no longer mentions the Parker 8FV12LN valve. ese previous and current references in sev- eral pharmacopeial compendia largely explain why one often finds the Parker 8FV12LN valve in inhaler testing laboratories. But, even for the specific valve described in the pharmaceutical compendia, there are no data in the literature that show this valve reaches a fixed flow rate when the pressure ratio is 0.5 or less. Surprising? Yes, especially for the informed test tech- nician who is reading the pharmacopeial method and wants to apply it. Now, digging one step further, our diligent techni- cian reads that the footnote "a" in the USP defines the flow coefficient Cv as follows: "Flow coefficient, as defined by ISA S75.02 'Control valve capacity test procedures in Standards and Recommended Prac- tices for Instrumentation and Control,' 10th ed., Vol. 2, Research Triangle Park, NC, Instrument Society of America, 1989." is method promises a defined test for quantifying Cv. en one might ask, "Are there data in the open literature that show this Parker valve has a maximum flow coefficient larger than or equal to 1 as specified in the USP?" A publication of such data would be very helpful, but there appears to be no such document. However,

Articles in this issue

view archives of Inhalation - INH0426